AzTrials
AzTrials

AsthmaV-TTG vs BINCT04373499

Virtual Teach-to-Goal Education vs. Brief Education for Children

A study testing Virtual Teach to Goal and Brief Intervention in people with Asthma and Bronchospasm, run by University of Chicago at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate the effectiveness of two different ways to teach hospitalized children how to use a metered dose inhaler and to follow-up after discharge home from the hospital to determine durability of the education. Read more about this study

Who is it for?
Ages 5 to 10 yearsHealthy volunteers can take part
Conditions the study is for
Asthma, Bronchospasm, Shortness of Breath
What is being tested?
Virtual Teach to Goal and Brief Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteUnited States
Study dates
16 Jan 2019to 31 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 10 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • The child is between the ages of 5-10 years old
  • The child is admitted for an asthma exacerbation, wheezing, or bronchospasm
  • The child is admitted to the Pediatric Hospital Medicine Service at Comer Children's Hospital
  • The child is prescribed albuterol

Who cannot join

  • The child/parent decline or unable to provide consent/assent, do not speak/read English
  • The child cannot use an inhaler by themselves without a mask
  • The child previously participated in this study
  • The child is currently in the pediatric intensive care unit (PICU)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Chicago Medicine

    Chicago, Illinois, 60637

Other trials in United States

About this study

Official title: A Randomized Clinical Trial Evaluating the Effectiveness of Virtual Teach-to-Goal Education vs. Brief Intervention for Children

The purpose of this study is to evaluate the effectiveness of two different ways to teach hospitalized children how to use a metered dose inhaler and to follow-up after discharge home from the hospital to determine durability of the education.

Read the detailed description

Asthma is the most common chronic childhood condition and has significant adverse consequences. One in 12 United States children has asthma, resulting in 13.4 million missed school days, 1 million emergency department visits, and 140,000 hospitalizations annually.

A key barrier to self-management of asthma is improper use of respiratory inhalers, which limits disease control. Better inhaler technique is associated with improved asthma outcomes for children. Assessment and education of inhaler technique are recommended at all healthcare encounters, however it is limited in practice because it is resource intensive (both personnel and time) and lacks fidelity. Thus, low-resource interventions that accurately teach inhaler skills are needed to impact pediatric asthma outcomes.

Teach-to-Goal (TTG) is a patient-centered strategy that uses tailored rounds of teaching and assessments to ensure mastery of inhaler technique. Studies show it is effective but resource intensive. A "virtual TTG" (V-TTG) intervention represents an opportunity to deliver inhaler technique education with a high-fidelity, low-resource, and feasible strategy. The module utilizes innovative learning technology with video demonstrations and assessment questions to tailor education to each user; the cycles of assessment and education continues until satisfactory mastery is achieved.

This study evaluates the comparative effectiveness of this high-fidelity, low-resource, and feasible model (V-TTG) versus a standardized brief intervention that mimics usual care to deliver tailored inhaler technique education to children with severe asthma via a randomized clinical trial.

Being tested
Virtual Teach to Goal, Brief Intervention
Keywords
Inhaler, Education, Asthma, Learning, Module, Virtual Teach to Goal
Medical subject headings
Asthma, Bronchial Spasm, Dyspnea

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Teach to GoalBehavioural

    Also called VTTG

    Virtual Teach-to-Goal is an educational module that teaches children how to use their inhaler properly; this is done with an IPAD. In the module, the child will complete a series of questions as a pre-assessment, watch a video about how to use the inhaler properly, and then answer a series of questions as a post-assessment. If a child answers any questions incorrectly, they will watch the video again and have another chance to answer the incorrect questions. The child will receive instruction by video one or multiple times (up to 3 times), depending on how much they understand after each round of instruction, as demonstrated by their responses to questions.

  • Brief InterventionBehavioural

    Also called BI

    There is a handout that describes proper inhaler technique. The RA reads the handout to the child.

Study groups in NCT04373499
Study groupRoleWhat they receive
Virtual Teach-to-Goal (V-TTG)ExperimentalThe RA will show the patient how to use the tablet to access the education module and be available for questions about the technology / tablet but not about the content. Within the module, the child will: * answer questions about how to use the inhaler as part of a pre-video assessment. * watch a video about how to correctly use a Metered Dose Inhaler (MDI) and spacer. * answer questions on the tablet to assess how well they understand how to use the inhaler. If a child answers any questions incorrectly, they will watch the video again and have another chance to answer the incorrect questions. The child will receive instruction by video one or multiple times (up to 3 times), depending on how much they understand after each round of instruction, as demonstrated by their responses to questions.
Receives: Behavioral: Virtual Teach to Goal
Brief Intervention (BI)Active comparatorThe RA will give the patient a handout about inhaler technique and read the steps to the child.
Receives: Behavioral: Brief Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of participants with metered dose inhaler (MDI) misuse immediately after V-TTG vs. BI education

    Evaluate effectiveness of V-TTG as compared to BI as measured by inhaler technique post-intervention. This will provide data on the short-term effectiveness of the interventions. Each patient's inhaler technique will be assessed using validated inhaler checklists by the trained assessor.

    Measured: Initial study visit / baseline

Secondary outcomes (4)
  1. Acceptability of V-TTG among children and parents based on Likert-scale questions (1-5)

    Questionnaires of children and parents immediately after completing the V-TTG intervention. Likert-scale questions will focus on whether children and parents like the V-TTG education, would be willing to use, and would recommend to a friend.

    Measured: Initial study visit - after completing V-TTG intervention

  2. Usability of V-TTG among children and parents based on open-ended questions

    Interviews with children and parents immediately after completing the V-TTG intervention. Open-ended questions will be utilized to assess what children and parents like or do not like about the module and how it could be utilized in clinical settings, at home, at school.

    Measured: Initial study visit - after completing V-TTG intervention

  3. Proportion of participants with metered dose inhaler (MDI) misuse in VTTG vs BI arms at 1 month after education

    Retention of proper inhaler technique skills

    Measured: Follow-up visit at 1 month

  4. Self-efficacy: Questionnaire

    Questionnaire with Likert-scale questions (1-5) to assess self-efficacy about inhaler technique pre vs post intervention

    Measured: Initial study visit - at baseline and immediately after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 May 2020
  2. Study start16 Jan 2019
  3. Primary completion27 Feb 2020
  4. Study completion31 Dec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
We will conduct a single-site randomized clinical trial of V-TTG versus brief intervention (BI) for school-aged children (5-11 years) with severe asthma hospitalized at University of Chicago Comer Children's Hospital. We aim to enroll 70 participants. The project team will identify eligible children who meet inclusion criteria. Block randomization will be utilized, stratified by age (5-8 vs. 9-11 years).
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04373499
Sponsor's protocol ID
18-1080
Acronym
V-TTG vs BI
Status last verified
Apr 2021
First submitted
9 Nov 2018
Last updated
29 Apr 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Volerman A, Balachandran U, Zhu M, Akel M, Hull A, Siros M, Luna V, Xu I, Press VG. Evaluating inhaler education interventions for hospitalized children with asthma: A randomized controlled trial. Ann Allergy Asthma Immunol. 2023 Aug;131(2):217-223.e1. doi: 10.1016/j.anai.2023.02.023. Epub 2023 Mar 3.

    PubMed 36870528

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Teach to Goal and Brief Intervention in people with Asthma and Bronchospasm, run by University of Chicago at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of participants with metered dose inhaler (MDI) misuse immediately after V-TTG vs. BI education (time frame: Initial study visit / baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04373499, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in